Torii Pharmaceutical Co., Ltd.
TRXPF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $115,854 | $14,683,000 | $17,093,000 | $15,024,000 |
| % Growth | -99.2% | -14.1% | 13.8% | – |
| Cost of Goods Sold | $66,302 | $8,059,000 | $12,076,000 | $8,232,000 |
| Gross Profit | $49,551 | $6,624,000 | $5,017,000 | $6,792,000 |
| % Margin | 42.8% | 45.1% | 29.4% | 45.2% |
| R&D Expenses | $9,055 | $677,000 | $628,000 | $833,000 |
| G&A Expenses | $0 | $3,763,000 | $1,340,000 | $3,887,000 |
| SG&A Expenses | $30,448 | $4,243,000 | $2,049,000 | $4,440,000 |
| Sales & Mktg Exp. | $0 | $480,000 | $709,000 | $553,000 |
| Other Operating Expenses | $0 | $0 | $203,000 | $0 |
| Operating Expenses | $39,504 | $4,920,000 | $2,880,000 | $5,273,000 |
| Operating Income | $10,048 | $1,704,000 | $2,137,000 | $1,519,000 |
| % Margin | 8.7% | 11.6% | 12.5% | 10.1% |
| Other Income/Exp. Net | $1,110 | $149,000 | -$81,000 | $173,000 |
| Pre-Tax Income | $11,158 | $1,853,000 | $2,056,000 | $1,692,000 |
| Tax Expense | $2,852 | $462,000 | $539,000 | $388,000 |
| Net Income | $8,306 | $1,391,000 | $1,517,000 | $1,304,000 |
| % Margin | 7.2% | 9.5% | 8.9% | 8.7% |
| EPS | 0.3 | 49.48 | 53.97 | 46.39 |
| % Growth | -99.4% | -8.3% | 16.3% | – |
| EPS Diluted | 0.3 | 49.48 | 53.97 | 46.39 |
| Weighted Avg Shares Out | 28,113 | 28,111 | 28,110 | 28,111 |
| Weighted Avg Shares Out Dil | 28,113 | 28,111 | 28,110 | 28,111 |
| Supplemental Information | – | – | – | – |
| Interest Income | $951 | $112,700 | $107,000 | $93,000 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $694 | $102,000 | $102,000 | $99,000 |
| EBITDA | $11,845 | $1,806,000 | $2,240,000 | $1,790,000 |
| % Margin | 10.2% | 12.3% | 13.1% | 11.9% |